{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:00:53Z","timestamp":1773680453978,"version":"3.50.1"},"reference-count":141,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thoracic.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Surgery Clinics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.thorsurg.2020.08.007","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T19:17:12Z","timestamp":1601579832000},"page":"367-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pathology of Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"30","author":[{"given":"Yin P.","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucian R.","family":"Chirieac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thorsurg.2020.08.007_bib1","series-title":"Pathology and genetics of tumors of the lung, pleura, thymus, and heart","author":"Travis","year":"2015"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.007_bib2","first-page":"935","article-title":"Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005","volume":"20","author":"Moolgavkar","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.thorsurg.2020.08.007_bib3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/CLEP.S105396","article-title":"Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival","volume":"8","author":"Beebe-Dimmer","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.thorsurg.2020.08.007_bib4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2471\/BLT.11.086678","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Delgermaa","year":"2011","journal-title":"Bull World Health Organ"},{"issue":"8","key":"10.1016\/j.thorsurg.2020.08.007_bib5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.15585\/mmwr.mm6608a3","article-title":"Malignant mesothelioma mortality\u2014United States, 1999-2015","volume":"66","author":"Mazurek","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"29","key":"10.1016\/j.thorsurg.2020.08.007_bib6","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2017.73.8401","article-title":"Long-term survival outcomes of cancer-directed surgery for malignant pleural mesothelioma: propensity score matching analysis","volume":"35","author":"Nelson","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.007_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/modpathol.2017.108","article-title":"Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma","volume":"31","author":"Vivero","year":"2018","journal-title":"Mod Pathol"},{"issue":"15","key":"10.1016\/j.thorsurg.2020.08.007_bib8","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.thorsurg.2020.08.007_bib9","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jtho.2019.04.029","article-title":"A\u00a0proposed system toward standardizing surgical-based treatments for malignant pleural mesothelioma, from the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce","volume":"14","author":"Friedberg","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"issue":"7","key":"10.1016\/j.thorsurg.2020.08.007_bib10","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jtho.2019.03.030","volume":"14","author":"Gomez","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(18)30765-4","article-title":"Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial","volume":"20","author":"Scherpereel","year":"2019","journal-title":"Lancet Oncol"},{"issue":"9254","key":"10.1016\/j.thorsurg.2020.08.007_bib12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(00)04013-7","article-title":"Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey","volume":"357","author":"Roushdy-Hammady","year":"2001","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.thorsurg.2020.08.007_bib13","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1379::AID-CNCR24>3.0.CO;2-Y","article-title":"Post-irradiation malignant mesothelioma","volume":"77","author":"Cavazza","year":"1996","journal-title":"Cancer"},{"issue":"36","key":"10.1016\/j.thorsurg.2020.08.007_bib14","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1200\/JCO.2013.49.9616","article-title":"Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma","volume":"31","author":"Chirieac","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.thorsurg.2020.08.007_bib15","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/1097-0142(19850501)55:9<1968::AID-CNCR2820550923>3.0.CO;2-9","article-title":"Malignant mesothelioma secondary to chronic inflammation and old scars. Two new cases and review of the literature","volume":"55","author":"Hillerdal","year":"1985","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.007_bib16","first-page":"250","article-title":"Malignant mesothelioma associated with chronic empyema with elevation of serum CYFRA19: A case report","volume":"2","author":"Kodama","year":"2008","journal-title":"Biosci Trends"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.007_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5858\/arpa.2017-0365-RA","article-title":"Malignant mesothelioma and its non-asbestos causes","volume":"142","author":"Attanoos","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1016\/j.thorsurg.2020.08.007_bib18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"issue":"16","key":"10.1016\/j.thorsurg.2020.08.007_bib19","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1158\/0008-5472.CAN-14-1328","article-title":"Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma","volume":"74","author":"Xu","year":"2014","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.007_bib20","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jtho.2016.12.006","article-title":"Improving the accuracy of mesothelioma diagnosis in China","volume":"12","author":"Guo","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"issue":"10","key":"10.1016\/j.thorsurg.2020.08.007_bib21","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/PAS.0b013e3182910c82","article-title":"Diffuse intrapulmonary malignant mesothelioma masquerading as interstitial lung disease: a distinctive variant of mesothelioma","volume":"37","author":"Larsen","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.007_bib22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/modpathol.3800543","article-title":"Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases","volume":"19","author":"Ordonez","year":"2006","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.thorsurg.2020.08.007_bib24","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/modpathol.2012.105","article-title":"Deciduoid mesothelioma: report of 21 cases with review of the literature","volume":"25","author":"Ordonez","year":"2012","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.007_bib25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/modpathol.2011.202","article-title":"Mesotheliomas with small cell features: report of eight cases","volume":"25","author":"Ordonez","year":"2012","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.007_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jcp.45.4.295","article-title":"Desmoplastic malignant mesothelioma: a review of 17 cases","volume":"45","author":"Wilson","year":"1992","journal-title":"J\u00a0Clin Pathol"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib27","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/modpathol.2009.180","article-title":"Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases","volume":"23","author":"Klebe","year":"2010","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.007_bib28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/01913128809064207","article-title":"Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma","volume":"12","author":"Henderson","year":"1988","journal-title":"Ultrastruct Pathol"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.007_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/019131290505176","article-title":"Lymphohistiocytoid mesothelioma: a clinical, immunohistochemical and ultrastructural study of four cases and literature review","volume":"28","author":"Yao","year":"2004","journal-title":"Ultrastruct Pathol"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.007_bib30","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/PAS.0b013e31802baad7","article-title":"Lymphohistiocytoid variant of malignant mesothelioma of the pleura: a series of 22 cases","volume":"31","author":"Galateau-Salle","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.thorsurg.2020.08.007_bib31","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jtho.2018.04.023","article-title":"New insights on diagnostic reproducibility of biphasic mesotheliomas: a multi-institutional evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center","volume":"13","author":"Galateau Salle","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.007_bib32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.5858\/arpa.2017-0295-OA","article-title":"Reproducibility of malignant pleural mesothelioma histopathologic subtyping","volume":"142","author":"Brcic","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41379-019-0320-y","article-title":"Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas","volume":"33","author":"Dacic","year":"2020","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.007_bib34","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1309\/AJCPHV33LJTVDGJJ","article-title":"Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy","volume":"130","author":"Arrossi","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib35","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/JTO.0b013e31820ce2c7","article-title":"Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma","volume":"6","author":"Kao","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"issue":"23","key":"10.1016\/j.thorsurg.2020.08.007_bib36","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1002\/cncr.32416","article-title":"Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma","volume":"125","author":"Chirieac","year":"2019","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0022-5223(19)41262-2","article-title":"Localized mesothelioma of the pleura: benign and malignant variants","volume":"75","author":"Okike","year":"1978","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"7","key":"10.1016\/j.thorsurg.2020.08.007_bib38","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/01.pas.0000165529.78945.dc","article-title":"Localized malignant mesothelioma","volume":"29","author":"Allen","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41379-019-0352-3","article-title":"Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel","volume":"33","author":"Marchevsky","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41379-019-0330-9","article-title":"Molecular characterization of localized pleural mesothelioma","volume":"33","author":"Hung","year":"2020","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.thorsurg.2020.08.007_bib41","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/00000478-200009000-00001","article-title":"The separation of benign and malignant mesothelial proliferations","volume":"24","author":"Churg","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.thorsurg.2020.08.007_bib42","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.5858\/arpa.2012-0112-RA","article-title":"The separation of benign and malignant mesothelial proliferations","volume":"136","author":"Churg","year":"2012","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.thorsurg.2020.08.007_bib43","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/PAS.0b013e31822a2481","article-title":"The fake fat phenomenon in organizing pleuritis: a source of confusion with desmoplastic malignant mesotheliomas","volume":"35","author":"Churg","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.thorsurg.2020.08.007_bib44","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.5858\/2005-129-1407-IDOEMA","article-title":"Immunohistochemical diagnosis of epithelioid mesothelioma: an update","volume":"129","author":"Ordonez","year":"2005","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2559.2007.02743.x","article-title":"Claudin-4 in mesothelioma diagnosis","volume":"51","author":"Facchetti","year":"2007","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5858\/arpa.2010-0216-RA","article-title":"Epithelioid lesions of the serosa","volume":"136","author":"Anttila","year":"2012","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.007_bib47","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/modpathol.2017.190","article-title":"Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma","volume":"31","author":"Amatya","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.thorsurg.2020.08.007_bib48","doi-asserted-by":"crossref","first-page":"45768","DOI":"10.1038\/srep45768","article-title":"HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma","volume":"7","author":"Tsuji","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.thorsurg.2020.08.007_bib49","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001469","article-title":"HEG1 is a highly specific and sensitive marker of epithelioid malignant mesothelioma","author":"Naso","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.007_bib50","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/modpathol.2016.181","article-title":"MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma","volume":"30","author":"Amatya","year":"2017","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.007_bib51","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41598-017-18545-x","article-title":"MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung","volume":"8","author":"Mawas","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.007_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.007_bib53","first-page":"14","article-title":"The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura","volume":"1","author":"Chirieac","year":"2011","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.thorsurg.2020.08.007_bib54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.humpath.2017.07.015","article-title":"The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell\/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center","volume":"67","author":"Marchevsky","year":"2017","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.007_bib55","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5858\/arpa.2018-0457-OA","article-title":"Differential diagnosis of epithelioid malignant mesothelioma with lung and breast pleural metastasis: a systematic review compared with a standardized panel of antibodies\u2014a new proposal that may influence pathologic practice","volume":"144","author":"Le Stang","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"10.1016\/j.thorsurg.2020.08.007_bib57","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000000394","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","volume":"39","author":"Sheffield","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.thorsurg.2020.08.007_bib58","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.thorsurg.2020.08.007_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2015.12.012","article-title":"Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma","volume":"51","author":"Andrici","year":"2016","journal-title":"Hum Pathol"},{"issue":"37","key":"10.1016\/j.thorsurg.2020.08.007_bib60","doi-asserted-by":"crossref","first-page":"59314","DOI":"10.18632\/oncotarget.10653","article-title":"Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma","volume":"7","author":"Carbone","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.thorsurg.2020.08.007_bib61","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry","volume":"104","author":"Hida","year":"2017","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.thorsurg.2020.08.007_bib62","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.5858\/arpa.2018-0273-OA","article-title":"Utility of methylthioadenosine phosphorylase compared with BAP1 immunohistochemistry, and CDKN2A and NF2 fluorescence in situ hybridization in separating reactive mesothelial proliferations from epithelioid malignant mesotheliomas","volume":"142","author":"Berg","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.thorsurg.2020.08.007_bib63","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.lungcan.2018.09.019","article-title":"A\u00a0combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis","volume":"125","author":"Kinoshita","year":"2018","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.007_bib64","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAS.0000000000000529","article-title":"Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.007_bib65","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/his.13127","article-title":"Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss","volume":"70","author":"Misumi","year":"2017","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.thorsurg.2020.08.007_bib66","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/cncr.28521","article-title":"Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma","volume":"120","author":"Joseph","year":"2014","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.007_bib67","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.pathol.2016.03.005","article-title":"Loss of expression of BAP1 is very rare in non-small cell lung carcinoma","volume":"48","author":"Andrici","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.thorsurg.2020.08.007_bib68","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.humpath.2016.10.005","article-title":"Loss of BRCA1-associated protein 1 (BAP1) expression is rare in non-small cell lung cancer","volume":"60","author":"Owen","year":"2017","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.007_bib69","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/PAS.0b013e31814faacf","article-title":"Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin","volume":"32","author":"Padgett","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.thorsurg.2020.08.007_bib70","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/PAS.0000000000000825","article-title":"GATA3 immunohistochemistry for distinguishing sarcomatoid and desmoplastic mesothelioma from sarcomatoid carcinoma of the lung","volume":"41","author":"Berg","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.007_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.007_bib72","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5858\/arpa.2015-0240-SA","article-title":"New markers for separating benign from malignant mesothelial proliferations: are we there yet?","volume":"140","author":"Churg","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib73","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/PAS.0b013e31826ab1c0","article-title":"IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations","volume":"37","author":"Lee","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib74","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41379-019-0347-0","article-title":"Malignant mesothelioma in situ: morphologic features and clinical outcome","volume":"33","author":"Churg","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib75","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41379-019-0310-0","article-title":"MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma","volume":"33","author":"Chapel","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib76","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41379-019-0411-9","article-title":"Cyclin D1 immunohistochemical staining to separate benign from malignant mesothelial proliferations","volume":"33","author":"Pors","year":"2020","journal-title":"Mod Pathol"},{"issue":"23","key":"10.1016\/j.thorsurg.2020.08.007_bib77","doi-asserted-by":"crossref","first-page":"34664","DOI":"10.18632\/oncotarget.8970","article-title":"Characterization of preneoplastic and neoplastic rat mesothelial cell lines: the involvement of TETs, DNMTs, and 5-hydroxymethylcytosine","volume":"7","author":"Roulois","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib78","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41379-018-0159-7","article-title":"Immunohistochemical evaluation of nuclear 5-hydroxymethylcytosine (5-hmC) accurately distinguishes malignant pleural mesothelioma from benign mesothelial proliferations","volume":"32","author":"Chapel","year":"2019","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.007_bib79","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00000478-198206000-00003","article-title":"Malignant mesothelioma: ultrastructural distinction from adenocarcinoma","volume":"6","author":"Warhol","year":"1982","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.thorsurg.2020.08.007_bib80","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0046-8177(98)90006-5","article-title":"Ultrastructural features of diffuse malignant mesotheliomas","volume":"29","author":"Oury","year":"1998","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib81","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-4608(01)00432-0","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma","volume":"127","author":"Sandberg","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.007_bib82","first-page":"2108","article-title":"Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas","volume":"9","author":"Illei","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.007_bib83","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00428-008-0689-3","article-title":"Prognostic significance of p16\/cdkn2a loss in pleural malignant mesotheliomas","volume":"453","author":"Dacic","year":"2008","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.007_bib84","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/modpathol.2008.45","article-title":"Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas","volume":"21","author":"Chiosea","year":"2008","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib85","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41379-019-0309-6","article-title":"Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma","volume":"33","author":"Kinoshita","year":"2020","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.007_bib86","doi-asserted-by":"crossref","first-page":"632","DOI":"10.5858\/arpa.2012-0108-OA","article-title":"p16 Deletion in sarcomatoid tumors of the lung and pleura","volume":"137","author":"Tochigi","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.thorsurg.2020.08.007_bib87","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib88","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Guo","year":"2015","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.007_bib89","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.007_bib90","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/s41467-019-09307-6","article-title":"Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications","volume":"10","author":"Blum","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.thorsurg.2020.08.007_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.12651","article-title":"Genetic alterations of malignant pleural mesothelioma: association to tumor heterogeneity and overall survival","author":"Quetel","year":"2020","journal-title":"Mol Oncol"},{"issue":"7","key":"10.1016\/j.thorsurg.2020.08.007_bib92","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib93","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/JTO.0000000000000436","article-title":"Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study","volume":"10","author":"Lo Iacono","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"issue":"47","key":"10.1016\/j.thorsurg.2020.08.007_bib94","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.1612074113","article-title":"High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma","volume":"113","author":"Yoshikawa","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.thorsurg.2020.08.007_bib95","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/PAS.0000000000000864","article-title":"A\u00a0subset of malignant mesotheliomas in young adults are associated with recurrent EWSR1\/FUS-ATF1 fusions","volume":"41","author":"Desmeules","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib96","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamaoncol.2017.2918","article-title":"Identification of ALK rearrangements in malignant peritoneal mesothelioma","volume":"4","author":"Hung","year":"2018","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.007_bib97","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/his.12779","article-title":"Anaplastic lymphoma kinase (ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum","volume":"68","author":"Loharamtaweethong","year":"2016","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib98","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jtho.2019.11.011","article-title":"Anaplastic lymphoma kinase gene rearrangement in children and young adults with mesothelioma","volume":"15","author":"Mian","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"issue":"28","key":"10.1016\/j.thorsurg.2020.08.007_bib99","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","article-title":"Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma","volume":"36","author":"Panou","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.thorsurg.2020.08.007_bib100","doi-asserted-by":"crossref","first-page":"9008","DOI":"10.1073\/pnas.1821510116","article-title":"Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy","volume":"116","author":"Hassan","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib101","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/0008-5472.CAN-15-0295","article-title":"Germline BAP1 mutational landscape of asbestos-exposed malignant mesothelioma patients with family history of cancer","volume":"76","author":"Ohar","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.thorsurg.2020.08.007_bib102","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.79.0352","article-title":"A\u00a0subset of mesotheliomas with improved survival occurring in carriers of BAP1 and other germline mutations","volume":"36","author":"Pastorino","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.007_bib103","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-13-2429","article-title":"Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition","volume":"20","author":"de Reynies","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.007_bib104","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0002-9440(10)62492-3","article-title":"Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling","volume":"166","author":"Gordon","year":"2005","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.007_bib105","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-05-3907","article-title":"Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction","volume":"66","author":"Lopez-Rios","year":"2006","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.007_bib106","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00000478-200404000-00013","article-title":"Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases","volume":"28","author":"Galateau-Salle","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.007_bib107","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41379-018-0127-2","article-title":"Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42","volume":"32","author":"Stevers","year":"2019","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.thorsurg.2020.08.007_bib108","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/PAS.0000000000000200","article-title":"Well-differentiated papillary mesothelioma with invasive foci","volume":"38","author":"Churg","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.007_bib109","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/modpathol.2017.153","article-title":"Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation","volume":"31","author":"Goode","year":"2018","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.007_bib110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.007_bib111","doi-asserted-by":"crossref","first-page":"e901","DOI":"10.1016\/j.cllc.2018.08.007","article-title":"Survival by histologic subtype of malignant pleural mesothelioma and the impact of surgical resection on overall survival","volume":"19","author":"Verma","year":"2018","journal-title":"Clin Lung Cancer"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.007_bib112","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/modpathol.2017.170","article-title":"Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study","volume":"31","author":"Rosen","year":"2018","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.thorsurg.2020.08.007_bib113","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/modpathol.2012.39","article-title":"Pleomorphic mesothelioma: report of 10 cases","volume":"25","author":"Ordonez","year":"2012","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.007_bib114","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/JTO.0b013e318211127a","article-title":"Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma","volume":"6","author":"Kadota","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.007_bib115","article-title":"Comprehensive molecular and pathological evaluation of transitional mesothelioma assisted by deep learning approach: a multi institutional study of the International Mesothelioma Panel from MESOPATH Reference Center","author":"Salle","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib116","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1092-9134(00)90036-4","article-title":"Mitotic and in situ end-labeling apoptotic indices as prognostic markers in malignant mesothelioma","volume":"4","author":"Beer","year":"2000","journal-title":"Ann Diagn Pathol"},{"issue":"9","key":"10.1016\/j.thorsurg.2020.08.007_bib117","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1158\/1078-0432.CCR-04-1884","article-title":"P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma","volume":"11","author":"Borczuk","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.007_bib118","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1378\/chest.128.5.3382","article-title":"Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma","volume":"128","author":"Demirag","year":"2005","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib119","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/modpathol.2011.146","article-title":"A\u00a0nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma","volume":"25","author":"Kadota","year":"2012","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.thorsurg.2020.08.007_bib120","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.jtho.2018.07.002","article-title":"Pathologic grading of malignant pleural mesothelioma: an evidence-based proposal","volume":"13","author":"Pelosi","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib121","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/PAS.0000000000001416","article-title":"Utility of nuclear grading system in epithelioid malignant pleural mesothelioma in biopsy-heavy setting: an external validation study of 563 cases","volume":"44","author":"Zhang","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.007_bib122","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jtho.2019.08.2506","article-title":"EURACAN\/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach","volume":"15","author":"Nicholson","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib123","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/his.13392","article-title":"The epithelioid BAP1-negative and p16-positive phenotype predicts prolonged survival in pleural mesothelioma","volume":"72","author":"Chou","year":"2018","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.007_bib124","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgu227","article-title":"Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival","volume":"36","author":"Baumann","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.thorsurg.2020.08.007_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.19.00048","article-title":"STRN-ALK rearranged malignant peritoneal mesothelioma with dramatic response following ceritinib treatment","volume":"3","author":"Ruschoff","year":"2019","journal-title":"JCO Precis Oncol"},{"issue":"17","key":"10.1016\/j.thorsurg.2020.08.007_bib126","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.thorsurg.2020.08.007_bib127","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/JTO.0000000000000177","article-title":"B7-H1 expression in malignant pleural mesothelioma is associated with sarcomatoid histology and poor prognosis","volume":"9","author":"Mansfield","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib128","doi-asserted-by":"crossref","first-page":"e0121071","DOI":"10.1371\/journal.pone.0121071","article-title":"Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)","volume":"10","author":"Cedres","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.thorsurg.2020.08.007_bib129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2016.01.010","article-title":"Immune biomarkers PD-1\/PD-L1 and TLR3 in malignant pleural mesotheliomas","volume":"52","author":"Combaz-Lair","year":"2016","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.007_bib130","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jtho.2017.02.013","article-title":"The immune microenvironment, genome-wide copy number aberrations, and survival in mesothelioma","volume":"12","author":"Thapa","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib131","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5858\/arpa.2019-0370-OA","article-title":"Use of programmed death ligand-1 (PD-L1) staining to separate sarcomatoid malignant mesotheliomas from benign mesothelial reactions","volume":"144","author":"Derakhshan","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib132","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41379-019-0328-3","article-title":"Expression of V-set immunoregulatory receptor in malignant mesothelioma","volume":"33","author":"Chung","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib133","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41379-019-0364-z","article-title":"V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma","volume":"33","author":"Muller","year":"2020","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.007_bib134","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/PAS.0000000000000511","article-title":"Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics","volume":"40","author":"Doyle","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.thorsurg.2020.08.007_bib135","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.22073","article-title":"Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma","volume":"52","author":"Antonescu","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.thorsurg.2020.08.007_bib136","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/gcc.20886","article-title":"A\u00a0novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites","volume":"50","author":"Errani","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.007_bib137","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ng0894-502","article-title":"Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma","volume":"7","author":"Clark","year":"1994","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.007_bib138","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00428-010-0975-8","article-title":"TLE1 expression in malignant mesothelioma","volume":"457","author":"Matsuyama","year":"2010","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib139","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng.2522","article-title":"Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors","volume":"45","author":"Chmielecki","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.007_bib140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.2509","article-title":"Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing","volume":"45","author":"Robinson","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.007_bib141","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/modpathol.2013.164","article-title":"Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics","volume":"27","author":"Doyle","year":"2014","journal-title":"Mod Pathol"}],"container-title":["Thoracic Surgery Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412720300694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412720300694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:33:36Z","timestamp":1761546816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547412720300694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":141,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1547412720300694"],"URL":"https:\/\/doi.org\/10.1016\/j.thorsurg.2020.08.007","relation":{},"ISSN":["1547-4127"],"issn-type":[{"value":"1547-4127","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathology of Malignant Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Thoracic Surgery Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thorsurg.2020.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}